{"id":31408,"date":"2012-12-27T19:59:58","date_gmt":"2012-12-28T00:59:58","guid":{"rendered":"http:\/\/1boringoldman.com\/?p=31408"},"modified":"2012-12-27T22:01:26","modified_gmt":"2012-12-28T03:01:26","slug":"kind-of-embarrassing","status":"publish","type":"post","link":"https:\/\/1boringoldman.com\/index.php\/2012\/12\/27\/kind-of-embarrassing\/","title":{"rendered":"kind of embarrassing…"},"content":{"rendered":"
The recent article in the Washington Post deserves reading, but you probably know everything it has to say. Here’s a simple point: <\/div>\n
\n
Antidepressants to treat grief? Psychiatry panelists with ties to drug industry say yes<\/a>
Washington Post with Bloomberg<\/font><\/strong>
By Peter Whoriskey
December 26, 2012<\/div>\n

It was a simple experiment in healing the bereaved: Twenty-two patients who had recently lost a spouse were given a widely used antidepressant. The drug, marketed as Wellbutrin, improved “major depressive symptoms occurring shortly after the loss of a loved one,” the report in the Journal of Clinical Psychiatry concluded.<\/strong><\/sup><\/p>\n

When, though, should the bereaved be medicated? For years, the official handbook of psychiatry, issued by the American Psychiatric Association, advised against diagnosing major depression when the distress is “better accounted for by bereavement.” Such grief, experts said, was better left to nature.<\/strong><\/sup><\/p>\n

But that may be changing. In what some prominent critics have called a bonanza for the drug companies, the American Psychiatric Association this month voted to drop the old warning against diagnosing depression in the bereaved, opening the way for more of them to be diagnosed with major depression — and thus, treated with antidepressants…<\/strong><\/sup><\/p>\n

While no evidence has come to light showing that committee members broadened the diagnosis to aid the drug companies, the process of developing the handbook was fraught with financial links to the industry:<\/strong><\/sup><\/div>\n